VXLLF (Vaxil Bio) Book Value per Share: $0.23 (As of Mar. 2026)


VXLLF Vaxil Bio Ltd VXLLF
38 GF Score
Price $0.03
! 2 Warning Signs
View Full Analysis

What is Vaxil Bio Book Value per Share?

Vaxil Bio VXLLF 38 Book Value per Share is $0.23 as of Mar. 2026. GuruFocus rates VXLLF with a GF Score™ of 38/100. The stock has 2 warning signs investors should review.

Vaxil Bio's book value per share for the quarter that ended in Mar. 2026 was $0.23.

During the past 12 months, Vaxil Bio's average Book Value Per Share Growth Rate was 31.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -6.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Vaxil Bio was 36.30% per year. The lowest was -75.60% per year. And the median was -25.10% per year.

Vaxil Bio's current price is $0.025. Its book value per share for the quarter that ended in Mar. 2026 was $0.23. Hence, today's PB Ratio of Vaxil Bio is 0.11.

During the past 13 years, the highest P/B Ratio of Vaxil Bio was 0.59. The lowest was 0.00. And the median was 0.00.


Vaxil Bio  (OTCPK:VXLLF) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.


Vaxil Bio Book Value per Share Related Terms


Vaxil Bio Book Value per Share Historical Data

* Premium members only.

The historical data trend for Vaxil Bio's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxil Bio Book Value per Share Chart

Vaxil Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Book Value per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.49 0.31 0.24 0.18 0.25

Vaxil Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Book Value per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.16 0.19 0.18 0.25 0.23

VXLLF vs VRTX, REGN, ALNY: Book Value per Share Comparison

For the Biotechnology subindustry, Vaxil Bio's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxil Bio PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxil Bio's PB Ratio distribution charts can be found below:

* The bar in red indicates where Vaxil Bio's PB Ratio falls into.


VXLLF
38GF Score
Vaxil Bio Ltd VXLLF
Book Value per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxil Bio Book Value per Share Calculation

Vaxil Bio's Book Value Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(0.99-0.00)/3.98
=0.25

Vaxil Bio's Book Value Per Share for the quarter that ended in Mar. 2026 is calculated as:

Book Value Per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(0.92-0.00)/3.98
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Frequently Asked Questions Learn more about Book Value per Share →
What does a Book Value per Share of $0.23 mean?
Vaxil Bio (VXLLF) has a Book Value per Share of $0.23 as of Mar. 2026. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Vaxil Bio and its competitors.
Is Vaxil Bio's Book Value per Share too high?
Vaxil Bio's current Book Value per Share is $0.23. Overall, Vaxil Bio has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Vaxil Bio's Book Value per Share compare to VRTX and REGN?
Vaxil Bio's Book Value per Share of $0.23 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Biotechnology company?
A good Book Value per Share depends on the Biotechnology industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Vaxil Bio and its competitors. Vaxil Bio's current Book Value per Share is $0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxil Bio stock overvalued right now?
Vaxil Bio (VXLLF) has a current Book Value per Share of $0.23. The current Book Value per Share is $0.23. Vaxil Bio's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Vaxil Bio (VXLLF), the current Book Value per Share is $0.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vaxil Bio Business Description

Other Exchanges VXL:Canada
Address 559 Briar Hill Avenue, Toronto, ON, CAN, M5N 1N1
Vaxil Bio Ltd is a biotechnology company focused on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. In recent years, the Company has been more focused on P-EsbpDOX. The Company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidates.
38GF Score

Get the complete analysis for VXLLF

Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.03
Price